Guggenheim Securities provides healthcare clients with independent insight and expertise across the biopharma, medical devices, tools and diagnostics, and healthcare services sectors.
Guggenheim Congratulates NewAmsterdam Pharma Corporation
Guggenheim Securities, LLC congratulates NewAmsterdam Pharma Corporation on the closing of its $479 million follow-on offering. Guggenheim served as joint bookrunner to New Amsterdam on the equity offering.
Guggenheim Congratulates Revolution Medicines on its Transaction
Guggenheim Securities, LLC congratulates Revolution Medicines on the closing of its $863 million follow-on offering. Guggenheim served as joint bookrunner to Revolution Medicines on the equity offering.
Dino Dedic Featured in Mergermarket Article
Senior Managing Director Dino Dedić, CFA, Healthcare Services Investment Banking, was highlighted in a recent Mergermarket article about the firm's work as exclusive financial advisor to eClinical Solutions, a portfolio company of Summit Partners, on its majority investment by GI Partners.
To access more information related to Healthcare at Guggenheim Securities, contact GSInfo@guggenheimpartners.com.
The information and materials provided herein (the “materials”) are provided for informational and educational purposes only and should not be considered a recommendation of any particular security, strategy or investment product, as investing advice of any kind, or as offering or providing any investment product or service, or as an offer or solicitation with respect to the purchase or sale of any investment by Guggenheim Securities, LLC or any of its affiliates (“Guggenheim”). The materials are not provided in an advisory or fiduciary capacity and may not be relied upon for or in connection with the making of investment decisions. The views expressed herein are solely those of the authors and may differ from the views of other officers, directors, employees or other representatives (as to any person or entity, its “Representatives”) of Guggenheim. The authors’ opinions are subject to change without notice. Guggenheim undertakes no obligation to provide additional information or any update to or correction of the information provided herein. Sources for the information contained herein are believed to be reliable, but the information is not guaranteed as to, and Guggenheim and its Representatives make no representation or warranty regarding, accuracy or completeness of any information contained herein or otherwise. Neither Guggenheim nor its Representatives shall be liable to any person in any way whatsoever for any losses, costs or claims for reliance on the materials. Guggenheim may have a business relationship with certain issuers mentioned herein, or may otherwise underwrite, hold a position, buy or sell as principal in the securities of any issuer mentioned. Guggenheim may have in the past provided, may currently be providing and may in the future seek to provide investment banking, financial advisory and other services to, and have other material relationships with, the issuers of securities, loans and other financial instruments referred to herein and their affiliates. With respect to any position Guggenheim may hold, Guggenheim may have interests different from or adverse to your interests. None of the materials provided may be reproduced or redistributed, in whole or in part, to any other person or published in whole or in part for any purpose absent the written consent of Guggenheim. By accessing or reviewing this website, you will be deemed to have acknowledged and agreed to the matters set forth above.
Copyright © 2023 by Guggenheim Securities, LLC, a FINRA registered broker-dealer. All rights reserved.